Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2019-07-26

Clinical Trial Update: Pharmacokinetics of Entospletinib in Adults With Normal and Impaired Liver Function [Phase 1]

View source ↗

Summary

Phase 1 pharmacokinetic study evaluating entospletinib in adults with normal versus impaired liver function; completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Entospletinib (entospletinib)

Snippet

Sponsor: Gilead Sciences | Conditions: Oncology | Phase 1 | Status: COMPLETED | Results posted: 2019-07-26